Enhanced locomotor activity in rats with excitotoxic lesions of the entorhinal cortex, a neurodevelopmental animal model of schizophrenia: Behavioral and in vivo microdialysis studies

Neuroscience Letters

Volumn 364, Issue 2, 2004, Pages 124-129

  Sumiyoshi, Tomiki ^a   Tsunoda, Masahiko ^a   Uehara, Takashi ^a   Tanaka, Kodai ^a   Itoh, Hiroko ^a   Sumiyoshi, Chika ^b   Kurachi, Masayoshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b FUKUSHIMA UNIVERSITY   (Japan)

Author keywords

Animal model; Dopamine; Entorhinal cortex; Locomotion; Nucleus accumbens; Schizophrenia

Indexed keywords

BUFFER; DOPAMINE; METHAMPHETAMINE; PHOSPHATE; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; ENTORHINAL CORTEX; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PERINATAL PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STEREOTYPY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE AGENTS; ENTORHINAL CORTEX; MALE; METHAMPHETAMINE; MICRODIALYSIS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; QUINOLINIC ACID; RATS; RATS, WISTAR; SCHIZOPHRENIC PSYCHOLOGY; STEREOTYPED BEHAVIOR; SYNAPTIC TRANSMISSION;

EID: 2942661780     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.04.027     Document Type: Article

References (47)

1. Arnold S.E., Hyman B.T., van Hoesen G.W., Damasio A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch. Gen. Psychiatry. 48:1991;625-632
2. Arnold S.E., Ruscheinsky D.D., Han L.-Y. Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol. Psychiatry. 42:1997;639-647
3. Bogerts B., Meertz E., Schonfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia: a morphometric study. Arch. Gen. Psychiatry. 42:1985;784-791
4. Breier A., Su T.P., Saunders R., Carson R.E., Kolachana B.S., de B.A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., Pickar D. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2569-2574
5. Brown R., Colter N., Corsellis J.A.N., Crow T.J., Frith C.D., Jagoe R., Johnstone E.C., Marsh L. Postmortem evidence of structural brain changes in schizophrenia: differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch. Gen. Psychiatry. 43:1986;36-42
6. Costall B., Naylor R.J., Olley J.E. The substantia nigra and stereotyped behavior. Eur. J. Pharmacol. 18:1972;95-106
7. Crow T.J. Positive and negative schizophrenic symptoms and dopamine. Br. J. Psychiatry. 137:1980;383-386
8. Crow T.J., Ball J., Bloom S.R., Brown R., Bruton C.J., Colter N., Frith C.D., Johnstone E.C., Owens D.G.C., Roberts G.W. Schizophrenia as an anomaly of development of cerebral asymmetry. Arch. Gen. Psychiatry. 46:1989;1145-1150
9. Du F., Eid T., Schwarcz R. Neuronal damage after the injection of aminooxyacetic acid into the rat entorhinal cortex: a silver impregnation study. Neuroscience. 82:1998;1165-1178
10. Eid T., Du F., Schwarcz R. Differential neuronal vulnerability to amino-oxyacetate and quinolinate in the rat parahippocampal region. Neuroscience. 68:1995;645-656
11. Falkai B., Bogerts B., Rozmek M. Limbic pathology in schizophrenia: the entorhinal region - a morphometric study. Biol. Psychiatry. 24:1988;515-521
12. Falkai P., Schneider-Axmann T., Honer W.G. Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol. Psychiatry. 47:2000;937-943
13. Finch D.M., Gigg J., Tan A.M., Kosoyan O.P. Neurophysiology and neuropharmacology of projections from entorhinal cortex to striatum in the rat. Brain Res. 670:1995;233-247
14. Flores G., Barbeau D., Quirion R., Srivastava L.K. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. J. Neurosci. 16:1996;2020-2026
15. Fuller T.A., Russchen F.T., Price J.L. Sources of presumptive glutamergic/aspartergic afferents to the rat ventral striatopallidal region. J. Comp. Neurol. 258:1987;317-338
16. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 41:1991;1-24
17. Harrison J.P. The neuropathology of schizophrenia; a critical review of the data and their interpretation. Brain. 122:1999;593-624
18. Itoh K., Fukumori R., Suzuki Y. Effect of methamphetamine on the locomotor activity in the 6-OHDA dorsal hippocampus lesioned rat. Life Sci. 34:1984;827-833
19. Jacob H., Beckmann H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J. Neural Transm. 65:1986;303-326
20. Kawasaki Y., Maeda Y., Urata K., Higashima M., Yamaguchi N., Suzuki M., Takashima T., Ide Y. A quantitative magnetic resonance imaging study of patients with schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 242:1993;268-272
21. Krayniak P.F., Meibach R.C., Siegel A. A projection from the entorhinal cortex to the nucleus accumbens in the rat. Brain Res. 30:1981;427-431
22. Krimer L.S., Herman M.M., Saunders R.C., Boyd J.C., Hyde T.M., Carter J.M., Kleinman J.E., Weinberger D.R. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cereb. Cortex. 7:1997;732-739
23. Krimer L.S., Hyde T.M., Herman M.M., Saunders R.C. The entorhinal cortex: an examination of cyto- and myeloarchitectonic organization in humans. Cereb. Cortex. 7:1997;722-731
24. M. Kurachi, M. Aso, M. Matsui, R. Shibata, Y. Tanii, Y.-J. Sun, T. Uehara, O. Saitoh, Medial temporal lobe structures and schizophrenia, in: N. Kato (Ed.), The Hippocampus: Functions and Clinical Relevance, Elsevier, Amsterdam, 1996, pp. 405-413.
25. Kurachi M., Shibata R., Sun Y.-J., Uehara T., Tanii Y., Suzuki M. Increased dopamine concentration and release in the amygdala following quinolinic acid lesions of the left entorhinal cortex in adult rat. Psychiatry Clin. Neurosci. 51:1996;S81
26. Kurachi M., Sumiyoshi T., Shibata R., Sun Y.-J., Uehara T., Tanii Y., Suzuki M. Changes in limbic dopamine metabolism following quinolinic acid lesions of the left entorhinal cortex in rats. Psychiatry Clin. Neurosci. 54:2000;83-89
27. Laruelle M., Abi D.A., vanDyck C.H., Gil R., D'Souza C.D., Erdos J., McCance E., Rosenblatt W., Fingado C., Zoghbi S.S., Baldwin R.M., Seibyl J.P., Krystal J.H., Charney D.S., Innis R.B. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. U.S.A. 93:1996;9235-9240
28. Lawrie S.M., Abukmeil S.S. Brain abnormality in schizophrenia. A systemic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psychiatry. 172:1998;110-120
29. Lipska B.K., Jaskiw G.E., Chrapusta S., Karoum F., Weinberger D.R. Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res. 585:1992;1-6
30. O'Donnell P., Grace A.A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J. Neurosci. 15:1995;3622-3639
31. O'Donnell P., Grace A.A. Phencyclidine interferes with the hippocampal gating of nucleus accumbens neuronal activity in vivo. Neuroscience. 87:1998;823-830
32. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 4th ed., Academic Press, 1998.
33. Roberts G.W. A neuropathological perspective. Br. J. Psychiatry. 158:1991;8-17
34. Schmajuk N.A., DiCarlo J.J. A neural network approach to hippocampal function in classical conditioning. Behav. Neurosci. 105:1991;82-110
35. Seeman P., Guan H.-C., Van Tol H.H.M. Dopamine D4 receptors elevated in schizophrenia. Nature. 365:1993;441-445
36. Shapiro R.M. Regional neuropathology in schizophrenia: where are we? Where are we going? Schizophr. Res. 10:1993;187-239
37. Shenton M.E., Kikinis R., Jolesz F.A., Pollak S.D., LeMay M., Wible C.G., Hokama H., Martin J., Metcalf D., Coleman M., McGarley R.W. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N. Engl. J. Med. 327:1992;604-612
38. Sorensen K.E. Projections of the entorhinal area to the striatum, nucleus accumbens, and cerebral cortex in the guinea pig. J. Comp. Neurol. 1985:1985;308-322
39. 3H ]raclopride binding in postmortem caudate of subjects with schizophrenia or major depression Brain Res. 681:1995;109-116
40. Swerdlow N.R., Lipska B.K., Weinberger D.R., Braff D.L., Jaskiw G.E., Geyer M.A. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology. 122:1995;27-34
41. Uehara T., Sumiyoshi T., Itoh H., Kurachi M. Modulation of stress-induced dopamine release by excitotoxic damage of the entorhinal cortex in the rat. Brain Res. 989:2003;112-116
42. Uehara T., Sumiyoshi T., Itoh H., Kurachi M. Inhibition of dopamine synthesis with alpha-methyl-p-tyrosine abolishes the enhancement of methamphetamine-induced extracellular dopamine levels in the amygdala of rats with excitotoxic lesions of the entorhinal cortex. Neurosci. Lett. 356:2004;21-24
43. Uehara T., Tanii Y., Sumiyoshi T., Kurachi M. Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain. Brain Res. 860:2000;77-86
44. Vaisanen J., Linden A.-M., Lakso M., Wong G., Heinemann U., Castren E. Excitatory actions of NMDA receptor antagonist in rat entorhinal cortex and cultured entorhinal cortical neurons. Neuropsychopharmacology. 21:1999;137-146
45. Wan R.-Q., Giovanni A., Kafka S.H., Corbett R. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behav. Brain Res. 78:1996;211-223
46. Weinberger D.R. Cell biology of the hippocampal formation in schizophrenia. Biol. Psychiatry. 45:1999;395-402
47. Wilkinson L.S., Mittleman G., Torres E., Humby T., Hall F.S., Robbins T.W. Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus. Behav. Brain Res. 55:1993;143-150